Skip to main content
Acta Pharmaceutica Sinica. B logoLink to Acta Pharmaceutica Sinica. B
. 2024 Apr 29;14(8):3783–3784. doi: 10.1016/j.apsb.2024.04.025

Author correction to ‘3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma’ [Acta Pharm Sin B 10 (2020) 301–312]

Wan Li a,b, Liwen Ren a,b, Xiangjin Zheng a,b, Jinyi Liu a,b, Jinhua Wang a,b,, Tengfei Ji b,, Guanhua Du a,b,
PMCID: PMC11365422  PMID: 39220872

The authors apologize for two inadvertent mistakes in Fig. 5: the image of immunofluorescence of LC3B in the Vehicle group (Fig. 5c) and the image of transmission electron microscope in the AKBA 10 μmol/L group (Fig. 5f) were provided incorrectly. The corrected Fig. 5 is shown below. The original data of these figures have been provided to the Editorial Office, and the corresponding authors or the Editorial Office can be contacted for original data access.

The authors apologize for any inconvenience caused to the journal and readers.

Image 1

Footnotes

Peer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.

Contributor Information

Jinhua Wang, Email: wjh@imm.ac.cn.

Tengfei Ji, Email: jitf@imm.ac.cn.

Guanhua Du, Email: dugh@imm.ac.cn.


Articles from Acta Pharmaceutica Sinica. B are provided here courtesy of Elsevier

RESOURCES